Apex Biotechnology Corp. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was TWD 2,005.337 million compared to TWD 2,198.862 million a year ago. Operating income was TWD 103.328 million compared to TWD 203.276 million a year ago. Net income was TWD 94.795 million compared to TWD 113.859 million a year ago. Basic earnings per share from continuing operations was TWD 0.95 compared to TWD 1.14 a year ago. Diluted earnings per share from continuing operations was TWD 0.87 compared to TWD 1.04 a year ago.